ABIGAIL WEIRAUCH: Open Payments
NPI 1508465543 · FRANKENMUTH, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$563 in 23 payments from 8 companies in 2025. Trend: 2023 $698 · 2024 $744 · 2025 $563
Food & beverage: $563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $160 |
| Neurocrine BioSciences, Inc. | 2 | $144 |
| Amgen Inc. | 3 | $63 |
| Novo Nordisk Inc | 3 | $54 |
| Exact Sciences Corporation | 2 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Lundbeck LLC | 1 | $22 |
Products named: INGREZZA, QULIPTA, REXULTI, KRYSTEXXA, Cologuard Collection Kit, Kerendia, Wegovy, UBRELVY.
Industry payments across MI — which companies pay providers there.
